Actively Recruiting
MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)
Led by University of Florence · Updated on 2024-09-19
100
Participants Needed
1
Research Sites
132 weeks
Total Duration
On this page
Sponsors
U
University of Florence
Lead Sponsor
T
Tubingen University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need for this study arises because this disease, in CAYA patients, is still poorly understood due to its rarity in individuals under 30 years old. This often leads to difficulties in assessing its severity and, consequently, in deciding on the necessary treatments to ensure the patient\'s recovery. The goal of this study is to examine melanoma in CAYA patients in order to gather the information needed to provide better diagnoses for affected patients and, as a result, select appropriate treatments to fight the disease and promote the patient\'s full recovery. Additionally, the data collected will be used to create a Pan-European online platform that will allow doctors across the European Union to consult the obtained data and collaborate on particularly complex melanoma cases, always with the aim of ensuring the patient\'s full recovery in the shortest possible time.
CONDITIONS
Official Title
MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient is an adolescent or child younger than 20 years or a young adult younger than 30 years
- Histologically confirmed diagnosis of melanoma or intermediate/ambiguous melanocytic neoplasm (such as melanocytomas, SAMPUS, IAMPUS, MELTUMP) according to WHO classification
You will not qualify if you...
- Adult patients older than 30 years
- Patients without a histologically confirmed diagnosis of melanoma or intermediate/ambiguous melanocytic neoplasm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Florence
Florence, Italy, Italy, 50139
Actively Recruiting
Research Team
D
Daniela Massi Professor
CONTACT
D
Dario Di Gangi Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here